Profound Medical Corp.
PROFNasdaqCIK 1628808HealthcareFiscal year ends Dec 31
Reports and events: 203 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2220:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-006781 |
| 2026-10-1412:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-006615 |
| 2026-10-0917:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-006559 |
| 2026-10-0720:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006499 |
| 2026-09-0401:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005884 |
| 2026-09-0311:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005868 |
| 2026-08-1712:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005580 |
| 2026-08-1711:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005575 |
| 2026-08-1320:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005500 |
| 2026-08-0620:32 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-092066 |
| 2026-08-0620:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005322 |
| 2026-07-2415:58 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004863 |
| 2026-07-1620:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004740 |
| 2026-07-1512:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004654 |
| 2026-05-1520:06 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-062509 |
| 2026-05-1421:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-003441 |
| 2026-05-0720:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-057198 |
| 2026-05-0720:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003160 |
| 2026-04-1612:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002497 |
| 2026-04-1411:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002426 |
| 2026-04-0112:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002146 |
| 2026-03-2712:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-001971 |
| 2026-03-1314:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-001553 |
| 2026-03-1020:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-025822 |
| 2026-03-0913:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-001406 |
| 2026-03-0521:32 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-024153 |
| 2026-03-0521:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001362 |
| 2026-02-1221:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000791 |
| 2026-02-1213:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000772 |
| 2026-02-0513:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000643 |
| 2026-01-2823:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000450 |
| 2026-01-1512:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000273 |
| 2026-01-1216:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000210 |
| 2026-01-0618:39 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000096 |
| 2025-12-3101:47 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-125344 |
| 2025-12-1921:36 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-123211 |
| 2025-11-2818:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-007654 |
| 2025-11-1321:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-111378 |
| 2025-11-1214:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-007224 |
| 2025-11-1213:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-007221 |
| 2025-11-1201:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-007188 |
| 2025-10-0712:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-006317 |
| 2025-08-1420:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005427 |
| 2025-08-1420:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001410578-25-001809 |
| 2025-06-0417:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-003672 |
| 2025-05-1421:20 ET | 8-K | 5.07 Shareholder vote results | 0001171843-25-003194 |
| 2025-05-0820:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002987 |
| 2025-05-0820:32 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001410578-25-001112 |
| 2025-04-2911:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-002572 |
| 2025-04-2900:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-002561 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.